These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor. Suzdak PD; Jansen JA Epilepsia; 1995 Jun; 36(6):612-26. PubMed ID: 7555976 [TBL] [Abstract][Full Text] [Related]
13. International experience with tiagabine add-on therapy. Ben-Menachem E Epilepsia; 1995; 36 Suppl 6():S14-S21. PubMed ID: 8595788 [TBL] [Abstract][Full Text] [Related]
14. [Determinants of tiagabine (TGB) efficacy and safety. A Polish multicenter study of 1307 patients with focal epilepsy]. Kozik A; Krause M Neurol Neurochir Pol; 2003; 37(3):537-46. PubMed ID: 14593750 [TBL] [Abstract][Full Text] [Related]
15. Seizures in a pediatric patient with a tiagabine overdose. Kazzi ZN; Jones CC; Morgan BW J Med Toxicol; 2006 Dec; 2(4):160-2. PubMed ID: 18072137 [TBL] [Abstract][Full Text] [Related]
17. Synergistic GABA-enhancing therapy against seizures in a mouse model of Dravet syndrome. Oakley JC; Cho AR; Cheah CS; Scheuer T; Catterall WA J Pharmacol Exp Ther; 2013 May; 345(2):215-24. PubMed ID: 23424217 [TBL] [Abstract][Full Text] [Related]
18. Tiagabine: a novel drug with a GABAergic mechanism of action. Gram L Epilepsia; 1994; 35 Suppl 5():S85-7. PubMed ID: 8039478 [TBL] [Abstract][Full Text] [Related]
19. Pre-clinical studies with the GABAergic compounds vigabatrin and tiagabine. Sills GJ Epileptic Disord; 2003 Mar; 5(1):51-6. PubMed ID: 12773297 [TBL] [Abstract][Full Text] [Related]
20. Long-term cognitive and EEG effects of tiagabine in drug-resistant partial epilepsy. Kälviäinen R; Aikiä M; Mervaala E; Saukkonen AM; Pitkänen A; Riekkinen PJ Epilepsy Res; 1996 Nov; 25(3):291-7. PubMed ID: 8956929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]